The historical rank and industry rank for Torrent Pharmaceuticals's FCF Margin % or its related term are showing as below:
NSE:TORNTPHARM'
s FCF Margin % Range Over the Past 10 Years
Min: 1.77 Med: 17.25 Max: 26.82
Current: 17.05
During the past 13 years, the highest FCF Margin % of Torrent Pharmaceuticals was 26.82%. The lowest was 1.77%. And the median was 17.25%.
NSE:TORNTPHARM's FCF Margin % is ranked better than 84.92% of 955
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs NSE:TORNTPHARM: 17.05
Torrent Pharmaceuticals FCF Margin % Related Terms
Torrent Pharmaceuticals FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:TORNTPHARM vs ZTS, UTHR: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Torrent Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Torrent Pharmaceuticals's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Torrent Pharmaceuticals (NSE:TORNTPHARM) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Torrent Pharmaceuticals and its competitors. Over the past decade, Torrent Pharmaceuticals' FCF Margin % has ranged from 1.77 to 26.82. According to the industry distribution chart, Torrent Pharmaceuticals ranks #144 out of 955 companies in the Drug Manufacturers industry, placing it in the top 15.1%.
Is Torrent Pharmaceuticals' FCF Margin % too high?
Torrent Pharmaceuticals' current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 1.77 to a high of 26.82. Based on the distribution chart, Torrent Pharmaceuticals ranks #144 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Torrent Pharmaceuticals has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Torrent Pharmaceuticals ranks #144 out of 955 companies for FCF Margin %. This places Torrent Pharmaceuticals in the top 15% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Historically, Torrent Pharmaceuticals' own FCF Margin % has ranged from 1.77 to 26.82 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Torrent Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Torrent Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (NSE:TORNTPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹4,296.81, compared to a current price of ₹4,516.20 — trading 5.1% above its estimated fair value. The current FCF Margin % is 0.00%. Torrent Pharmaceuticals' overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Torrent Pharmaceuticals (NSE:TORNTPHARM), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?
Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹4,516.20 is trading 5.1% above its estimated GF Value™ of ₹4,296.81.
GuruFocus considers Torrent Pharmaceuticals to be Fairly Valued.
Key valuation signals for NSE:TORNTPHARM:
FCF Margin %: 0.00%
GF Value™: ₹4,296.81 vs. price of ₹4,516.20 (5.1% above fair value)
No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
80GF Score
Get the complete analysis for NSE:TORNTPHARM
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TORNTPHARM has been successfully added to your 
